Effect of Ocrelizumab in Blood Leukocytes in Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
Neurol Neuroimmunol Neuroinflamm 2021 Jan 06;8(2)e940, JI Fernández-Velasco, J Kuhle, E Monreal, V Meca-Lallana, J Meca-Lallana, G Izquierdo, F Gascón-Giménez, S Sainz de la Maza, PE Walo-Delgado, A Maceski, E Rodríguez-Martín, E Roldán, N Villarrubia, A Saiz, Y Blanco, P Sánchez, E Carreón-Guarnizo, Y Aladro, L Brieva, C Íñiguez, I González-Suárez, LA Rodríguez de Antonio, J Masjuan, L Costa-Frossard, LM VillarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.